Therapeutic Anticoagulation in Non-Critically Ill Patients with Covid-19

Ryan Zarychanski(CancerCare Manitoba), Maria M. Brooks, Bridget‐Anne Kirwan, Lucy Z. Kornblith(San Francisco General Hospital), Scott Berry(Queen's University), Mary Cushman(University of Vermont), Brett L. Houston(CancerCare Manitoba), Matthew D. Neal(University of Pittsburgh), Patrick R. Lawler(McGill University Health Centre), Ewan C. Goligher(University Health Network), Arthur S. Slutsky(St. Michael's Hospital), Michael E. Farkouh(Cedars-Sinai Smidt Heart Institute), Harmony R. Reynolds(Anna Needs Neuroblastoma Answers), Marc Carrier(University of Ottawa), Elizabeth Lorenzi(Berry & Associates (United States)), Anthony Gordon(University of Copenhagen), Michelle N. Gong, Colin McArthur(Auckland City Hospital), Roger Lewis(University of California, Los Angeles), Alisa M. Higgins(Monash University), David T. Huang(University of Pittsburgh), Jorge Escobedo, Alexis F. Turgeon(Université Laval), Bryan J. McVerry(University of Pittsburgh), Susan R. Kahn(Jewish General Hospital), Keri S. Kim, Charlotte Bradbury(University of Bristol), Judith S. Hochman(New York University), Jeffrey S. Berger(New York University), Zoe McQuilten, Anand Kumar(All India Institute of Medical Sciences), Steven Webb(St John of God Subiaco Hospital), Lindsay R. Berry(Berry & Associates (United States)), Derek Angus, José Carlos Nicolau(Hospital São Paulo), Robert S Rosenson

medRxiv

May 17, 2021

Cited by 19

Related Papers

|New England Journal of Medicine|2017|9.1k

|Circulation|2018|7.2k

|New England Journal of Medicine|2019|6.8k

|Intensive Care Medicine|2017|6.8k

|New England Journal of Medicine|2017|5.5k